Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

  • There is currently no data for SNG
Date   Source Headline
6th Jul 20227:00 amRNSGrant of Options
30th Jun 20221:45 pmRNSResult of AGM
23rd Jun 20224:40 pmRNSSecond Price Monitoring Extn
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
15th Jun 20222:30 pmRNSHolding(s) in Company
9th Jun 20223:00 pmRNSExercise of Options and Total Voting Rights
6th Jun 20224:25 pmRNSPosting of Annual Report & Notice of AGM
25th May 20227:00 amRNSFull Year Results
18th May 20224:36 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSSynairgen presents at ATS 2022
25th Apr 20227:00 amRNSPresentation at ECCMID
19th Apr 20224:40 pmRNSSecond Price Monitoring Extn
19th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20222:10 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSSynairgen to present at ATS 2022
17th Mar 20227:25 amRNSSynairgen Provides Update on ACTIV-2 Trial
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
11th Mar 20224:40 pmRNSSecond Price Monitoring Extn
11th Mar 20224:35 pmRNSPrice Monitoring Extension
8th Mar 20224:35 pmRNSHolding(s) in Company
8th Mar 20223:52 pmRNSHolding(s) in Company
4th Mar 20221:36 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSUpdate on SNG001
24th Feb 202211:30 amRNSHolding(s) in Company
23rd Feb 202211:25 amRNSHolding(s) in Company
21st Feb 20227:00 amRNSTopline results from Phase 3 SPRINTER trial
4th Feb 20224:54 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20222:05 pmRNSHolding(s) in Company
12th Jan 202211:53 amRNSHolding(s) in Company
7th Jan 20225:25 pmRNSHolding(s) in Company
6th Jan 202212:00 pmRNSSynairgen announces partnership with Ashfield
23rd Dec 20214:15 pmRNSHolding(s) in Company
23rd Dec 20212:19 pmRNSHolding(s) in Company
21st Dec 20215:05 pmRNSHolding(s) in Company
8th Dec 20217:00 amRNSData Presented at ESWI Influenza Conference
6th Dec 20215:30 pmRNSHolding(s) in Company
6th Dec 20217:00 amRNSSynairgen Presents SNG001 Data at ESWI
19th Nov 20212:26 pmRNSHolding(s) in Company
11th Nov 20217:00 amRNSSynairgen completes Phase III recruitment
8th Nov 202112:58 pmRNSHolding(s) in Company
26th Oct 20213:13 pmRNSHolding(s) in Company
21st Oct 20215:39 pmRNSHoldings in Company
21st Oct 20217:00 amRNSGrant of Options
20th Oct 20217:00 amRNSSNG001 progresses to Phase 3 of ACTIV-2 trial
13th Oct 20217:00 amRNSSynairgen appoints Gareth Walters, Ph.D. as CRO
5th Oct 202111:25 amRNSHolding(s) in Company
30th Sep 20217:02 amRNSNon-Executive Director Appointment
30th Sep 20217:00 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.